Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.

Recent

Keosys
3 Reasons Why You Should Perform Quality Control in Centralized Imaging
Today, more and more clinical trials are being conducted internationally,..
Keosys
The Importance of Centralized Medical Imaging: From Early-Phase to Post-Phase IV Clinical Trials
Medical imaging is a technique used in the field of medicine to create visual..
From Cheson 1999 to RECIL: Evolution of the Response Assessment Criteria in Lymphoma
Lymphoma can be defined as a type of cancer that affects the lymphatic system,..
130 Years of Radiography: A brief history
Medical imaging could be described as the different techniques and processes..
Keosys
3 Things your Imaging CRO Needs in 2023
Imaging CROs provide critical expertise that can help to optimize clinical..
Keosys
Interview: 2022 in Review with Oana Popa-Nita
2022 Year in Review 2022 is coming to a close, and it’s a great time to reflect..
Keosys
The Best Keosys Blogs of 2022
Recap: Top blog posts of 2022 It’s been a great year for Keosys, the..
Keosys
Prostate Cancer Resource Page
Prostate Cancer Resource Page Prostate cancer is the second most common cancer..
Keosys
Evaluating Tumor Response
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
Interview: An Immunotherapeutic Drug Development Expert Discusses Future of Cancer Management
William Le brings nearly 20 years of experience in drug development in oncology..
Keosys
Prostate Cancer and Imaging
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
HU, SUV, and More: Different Metrics in The World of Imaging
Medical imaging is an essential tool in healthcare for diagnosis, treatment,..
Keosys
Prostate Cancer Working Group 3: Imaging Assessments Infographic
Prostate Cancer Working Group 3 (PCWG3) is an international working group of..
Dr. Constance Fourcade
Deformable Image Registration with Deep Network Priors: A Study on Longitudinal PET Images
Introduction Metastatic breast cancer requires constant monitoring, usually..
Keosys
Interview: A Clinical R&D Expert Talks About the Future of Radiopharmaceuticals
With a background in clinical research and development, UK-trained physician..
Keosys
Why are so many imaging queries sent to your site and how can you avoid them?
Why are so many imaging queries sent to your site and how can you avoid them?..
Keosys
Heptocellular Carcinoma (HCC) Resource Page
Hepatocellular Carcinoma (HCC) is the most common cancer of the liver and the..
Keosys
Focus On Selective Internal Radiation Therapy with HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
Evaluating Tumor Response in HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
Interview: An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today
Dr. Yan Rolland, head of the diagnosis and interventional radiology department..
Keosys
Interview: A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More
Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..
Keosys
Interview: Keosys Advances into a Promising New Year
With our 20th anniversary year recently completed and a new year underway, we..
Case Study - Setting up a Project in a Short Turnaround Time
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Automatic Segmentation of Metastatic Breast Cancer Lesions on F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment
Introduction Metastatic breast cancer patients receive lifelong medication and..
Modified Recist for HCC with Infographic
mRECIST was developed in 2010 to adapt RECIST v1.1 to the particularities of..
Questions to Ask Yourself About Imaging in Clinical Trials
Starting a trial can be very challenging. There are many actors involved and..
5 Myths About Imaging CROs
In the race against COVID, clinical trials regularly made the headlines. People..
Keosys
How to Prepare an Imaging Study While Minimizing Budget and Risk
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Automatic Quantification of Background Activity in the PERCIST Criteria
Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) allows..
Photography as Imaging in Dermato-Oncology Clinical Trials
The health industry has been impacted by numerous technological advances in..
Case Study - Rescuing a Complicated Trial
Complex trials with multiple efficacy endpoints or multiple imaging modalities..
Keosys
Interview: A Medical Doctor Finds Her Biotech Home
We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..
Lucie Rivière
An Overview of the Latest Innovations in Imaging Technology
The health industry has been impacted by numerous technological advances in..
Lucie Rivière
Considering the Latest in Drug Development
Every day, scientists and researchers work to improve our health. Today more..
Keosys
Keo-Tales: Introducing the Keosys Interns
Every year, Keosys takes on a select number of interns, giving them the..
Keosys
Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
Keosys
iRECIST and Tumor Response to Immunotherapy with Infographic
iRecist and Tumor Response to Immunotherapy When immunotherapy is used to treat..
Keosys
Keo-Tales: Looking Back and Looking Forward
Keosys is an imaging solutions provider supporting biopharmaceutical companies..
Keosys
Read Criteria and the Evaluation of Antitumor Responses With Immunotherapeutic Agents
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
Keosys
Imaging CROs Role in Clinical Research with Infographic
The use of imaging endpoints in clinical trials has steadily grown over the..
Keosys
Project Manager Stephanie Graf Joins the Keosys Team in the US
We are pleased to welcome Stephanie Graf to our Project Management team in the..
Keosys
Interview: Cancer Insight Leverages a Surgical Oncologist's Long Commitment to Service and Research
We recently spoke with George E. Peoples, M.D., founder and Chief Executive..
Keosys
Interview: Global Perspectives from a Global Powerhouse, Syneos Health
We recently spoke with Patrick Nealon, Executive Vice President and General..
Medical Imaging Data Synthesis using Generative Adversarial Networks
Combining different modalities as done with PET/CT, clinical decision making is..
Deep Learning Approaches for Bone and Bone Lesion Segmentation on 18FDG PET/CT Imaging in the Context of Metastatic Breast Cancer
Introduction In the context of metastatic breast cancer, tumor segmentation can..
Keosys
Interview: OncoBay Clinical Redefines What's Possible for CROs
We recently spoke with OncoBay Clinical executives Krystyna Kowalczyk, CEO, and..
Keosys
Interview: Orano Med and Leading in Nuclear Medicine
We recently spoke with Jason Hurt, MD, chief medical officer for Orano Med, a..
The Importance of Imaging Review Charters in Clinical Trials
When imaging is part of a clinical trial, two unique documents must be..
The Importance of Imaging Acquisition Guidelines in Clinical Trials
There are numerous documents that demand serious attention as a clinical trial..
Keo-Tales: Introducing the Business Developer Role with Lauren Pennock
Lauren Pennock is a Business Developer managing the European market. She has..
RECIST Imaging Criteria in Clinical Trials with Infographic
Medical imaging has been used in clinical trials to assess tumor response for..
Laurence Boy-Machefer
Keo-Tales:Introducing the QA/RA role with Laurence Boy-Machefer
Laurence Boy-Machefer is Head of Quality Assurance and Regulatory Affairs. She..
Keo-Tales:Introducing the Software Developer Role with Romain Bénéteau
Romain Bénéteau is a software engineer specializing in Java. He has been..
Keo-Tales: Introducing the Project Management Role with Pierre-Olivier Desmoulins
Pierre-Olivier Desmoulins is a Senior Clinical Trial Project Manager with 20+..
Imaging and the Treatment of Prostate Cancer: A Productive Relationship
First described in 1853, prostate cancer was originally thought to be rare...
The Language of Acronyms in Imaging - WDTM?
Acronyms are everywhere. We use them ubiquitously at work, on social media, and..
Interventional Radiology: From “Angioplasty” to Leadership in 21st-Century Innovation
The seeds of the discipline that would become interventional radiology, the use..
Automatic Segmentation of Liver Metastases in PET/CT Imaging with Deep Learning
Introduction In the context of metastatic breast cancer treatment, PET/CT..
Latest Update of Imagys from Keosys Includes Tools to Monitor Reader Performance in Real Time
Monitoring reader performance is crucial in clinical trials as reader..
Active Organ Segmentation in Metastatic Breast Cancer Images Combining Superpixels and Deep Learning Methods
Introduction In the clinical follow-up of metastatic breast cancer patients,..
Laurence Boy-Machefer
Don't Overlook GCP in Imaging
Good clinical practice (GCP) is not just a set of texts; it’s the testimony of..
What Does a First-Rate Medical Imaging CRO Look Like in 2021?
Today, medical imaging CROs (ICROs) are more likely than ever to be a key asset..
The Comparison Between Traditional and Deep Learning-Based Semi-Automatic Segmentation Methods for Metastatic Breast Cancer Lesion Monitoring
Introduction Breast cancer is the most common cancer in women and the second..
Why Calibration Meetings are Good for Central Imaging Reviews and How to Organize Them
Imaging endpoints are used in clinical trials to determine drug safety and..
3 Reasons to Watch Out for Our Latest Software Release
The world of research and clinical trials moves fast but technology goes..
The Use of Phantoms for Cross-Calibration in Clinical Trials
The advent of oncology and other disease treatments that require the collective..
Lymphoma: The Role of Imaging in Diagnosis, Treatment, and Monitoring
Historically, computed tomography (CT) has been the main imaging modality used..
AI in Medical Imaging: The Kidney Tumor Segmentation Challenge
Precise characterization of the kidney and kidney tumor characteristics is of..
Keosys
The Role of Medical Imaging in PRRT
This is an excerpt from Keosys' free eBook, "An Introduction to Peptide..
Cross-calibrating PET Scanners in Clinical Trials: Why and How
Numerous elements of PET imaging are subject to variability, such as scan..
Keosys
What's New in PRRT Research and Development
This is an excerpt from Keosys' free eBook, "An Introduction to Peptide..
Keosys
What is PRRT and Which Conditions Does it Benefit?
This is an excerpt from Keosys' free eBook, "An Introduction to Peptide..
Read Designs and the FDA's Guidance on Imaging Process Standards
We previously introduced the concept of imaging read designs in clinical..
The Biggest Trends at the 2019 ASCO Annual Meeting
Last week the American Society of Clinical Oncology annual meeting took place..
Six Ways to Decrease Reader Variability in Clinical Trials
Medical imaging is used to detect tumors and measure changes in their size over..
The Challenges of Imaging Biomarker Development
Imaging biomarkers are often pivotal components of a clinical trial, from..
The Power of Flexible, Independent Central Review in Clinical Trials
Medical imaging has been used for decades in the evaluation and development of..
AI in Medical Imaging
At the beginning of the year, an article in Nature Medicine was published that..
Challenges in Immuno-Oncology Clinical Trials: Impact on Imaging
Immuno-oncology is one of the most-watched medical research areas of the 21st..
What You Need to Know About Imaging Read Criteria in Clinical Trials
This is an excerpt from Keosys' free eBook, "The Non-Expert's Guide to Clinical..
4 Important Factors to Consider When Using Imaging in Clinical Trials
This is an excerpt from Keosys' free eBook, "The Non-Expert's Guide to Clinical..
What You Need to Know About Imaging Read Designs in Clinical Trials
This is an excerpt from Keosys' free eBook, "The Non-Expert's Guide to Clinical..
RANO Criteria for Clinical Trials
An earlier post provided a broad overview of the various imaging criteria that..
The Use of Imaging in Clinical Trial Patient Selection
An earlier post touched briefly on the use of nuclear imaging in clinical..
Neuroendocrine Tumors: Where Diagnosis and Treatment Meet
Neuroendocrine tumors (NETs) arise from hormone-producing cells that form part..
Dosimetry and Its Use in Clinical Trials
Nuclear imaging-based biomarkers and targeted radiotherapy are integral..
What is PET Imaging and How is it Used in Clinical Trials?
Positron emission tomography (PET) imaging is widely used to assess tumoral..
Four Key Things to Consider When Selecting an Imaging CRO
In the clinical study process, medical imaging is becoming more common as..
Recent Drug Approvals Based on Imaging Results
Medical imaging is an essential component for clinical drug development from..
What is Nuclear Imaging?
As noted in a previous post, positron emission tomography (PET)—a nuclear..
ESMO 2018: Meeting Highlights
One of the premier forums to discuss cancer drug development took place in..
Choosing the Appropriate Imaging Modality and Imaging Criteria for Your Target Condition
The application of advanced imaging methods streamlines the clinical trial..
What is a Medical Imaging CRO?
In the life science industry, there are biopharma companies who carry out..
The Benefits of an Integrated Medical Imaging System in Clinical Trials
If you have a friend that lives out of town and has an upcoming birthday, you..
The Evolution of Keosys
It’s been 10 years since we made our foray into the clinical trial arena, and..
A Quick Guide to Medical Imaging in Clinical Trials
Medical imaging is a key asset in the drug development process as it can..

More Posts

New call-to-action

Information

Europe

13 Impasse Serge Reggiani
44800 Saint-Herblain
FRANCE

Phone: +33 2 53 59 12 90

North America

55 Fifth Avenue Suite 1807
New York, NY 10003 
USA

Phone: +1 646 797 2724